Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ATNM holding history

Actinium Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ATNM overviewAll 13F holders of ATNMFull Q2 2026 holdings

Shares (Q2 2026)
6,758
Value
$6.62K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ATNM by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,758$6.62K<0.1%−7,860−53.8%ReducedHolders
Q1 202614,618$14.5K<0.1%+14,522+15,127.1%AddedHolders
Q4 202596$131<0.1%−14,480−99.3%ReducedHolders
Q3 202514,576$23.3K<0.1%−11,014−43.0%ReducedHolders
Q2 202525,590$35.8K<0.1%−370,546−93.5%ReducedHolders
Q1 2025396,136$637.8K<0.1%+307,320+346.0%AddedHolders
Q4 202488,816$111.9K<0.1%+51,837+140.2%AddedHolders
Q3 202436,979$69.5K<0.1%+14,205+62.4%AddedHolders
Q2 202422,774$168.5K<0.1%−4,942−17.8%ReducedHolders
Q1 202427,716$217.0K<0.1%−2,041−6.9%ReducedHolders
Q4 202329,757$151.2K<0.1%+17,594+144.7%AddedHolders
Q3 202312,163$72.0K<0.1%+12,163NewHolders
Q2 20230$00.0%−2,704−100.0%Sold outHolders
Q1 20232,704$25.6K<0.1%−531−16.4%ReducedHolders
Q4 20223,235$34.5K<0.1%+1,399+76.2%AddedHolders
Q3 20221,836$13.0K<0.1%+1,800+5,000.0%AddedHolders
Q2 202236$00.0%+36NewHolders
Q1 20220$00.0%−50−100.0%Sold outHolders
Q4 202150$00.0%−100−66.7%ReducedHolders
Q3 2021150$1.00K<0.1%−2,693−94.7%ReducedHolders
Q2 20212,843$22.0K<0.1%+2,693+1,795.3%AddedHolders
Q1 2021150$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.